India, April 9 -- Google is taking its collaboration with Intel to the next level by committing to incorporate several generations of Intel's CPUs into its AI data centers. This move comes as Intel ai... Read More
India, April 9 -- Amazon's CEO Andy Jassy is standing firm on the company's big spending in artificial intelligence, as he highlighted in his annual letter to shareholders. He believes that the hefty ... Read More
India, April 9 -- Amazon is set to discontinue support for older Kindle devices released in 2012 or earlier, and this has sparked frustration among loyal users. With this change, devices affected-inc... Read More
India, April 9 -- Starting May 20, 2026, Amazon is set to discontinue support for older Kindle devices released in 2012 or earlier, and this has sparked frustration among loyal users. With this chang... Read More
India, April 8 -- AtaiBeckley Inc. (ATAI) has reported new Phase 2a data showing that a single intranasal dose of its investigational therapy BPL-003 produced a rapid and durable antidepressant respon... Read More
India, April 8 -- BioXcel Therapeutics, Inc. (BTAI) has enrolled the first patients in a U.S. Department of War-funded phase 2a study evaluating BXCL501, its sublingual dexmedtomidine film, for the tr... Read More
India, April 8 -- Plus Therapeutics, Inc. (PSTV) said on Wednesday that the U.S. Food and Drug Administration has granted Orphan Drug Designation to REYOBIQ for the treatment of pediatric malignant gl... Read More
India, April 8 -- United Therapeutics Corporation (UTHR), Wednesday announced that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation to the company's... Read More
India, April 8 -- ProQR Therapeutics N.V. (PRQR), a company developing RNA editing therapies through its Axiomer platform, has unveiled a new AI-driven strategy that includes a partnership with Ginkgo... Read More
India, April 8 -- Adagio Medical Holdings, Inc. (ADGM) has received Investigational Device Exemption (IDE) approval to expand its FULCRUM-VT trial and evaluate its next-generation vCLAS Ultra-Low Temp... Read More